Skip to main content
School of Public Health
block W logo University of Washington

Sean D. Sullivan

faculty photo
The fertility of our minds to invent health care technology must now be matched by a commitment to assess and identify its appropriate use.
Professor, Health Services
Dean, School of Pharmacy
Professor, Pharmacy (primary appt.)
Adjunct Professor, Medicine


PhD   University of California (Berkeley), 1992   (Health Economics)
MS   University of Texas (Austin), 1986   (Pharmacy)
BS   Oregon State University, 1983   (Pharmacy)

Contact Info


office:   H-375, Health Sciences Building

1959 NE Pacific Street
Seattle, WA 98195-7630

campus box:   357630
voice:   206-685-8153
fax:   206-543-3835


Sean D. Sullivan is Professor and Dean of the University of Washington School of Pharmacy. In addition to his joint appointment as Professor of Health Services, He also holds adjunct appointments in the School of Medicine, the Public Health Sciences Division at the Fred Hutchinson Cancer Research Center, and at Kaiser Permanente Washington Health Research Institute.

Dr. Sullivan has authored more than 400 journal articles, book chapters, task force reports and organizational and governmental publications. In many of these, he has assessed the evidence and applications of medical technology in relation to coverage and reimbursement decisions. His research interests include technology assessment, medical decision-making and economic evaluation of medical technology. He is past president of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and past chair of the Academy of Managed Care Pharmacy (AMCP) executive committee of the Format for Formulary Submissions – the United States evidence-based guidelines for formulary decision-making.

Dr. Sullivan served as a member of the Medicare Evidence Development and Coverage Advisory Committee, a member of the Regence Blue Shield and Premera Blue Cross P/T Committee and chair, Premera Blue Cross Value Assessment Committee. He is also on the editorial boards of Value in Health, PharmacoEconomics, and Journal of Medical Economics. He was awarded the 2014 Stephen G. Avey Lifetime Achievement Award from the Academy of Managed Care Pharmacy and the 2015 APhA Academy of Pharmaceutical Research Sciences (APRS) Research Achievement Award.

Technology assessment; medical decision making; economic evaluation of pharmaceuticals, particularly in the areas of respiratory disorders, organ transplantation, HIV/AIDS, mental health and clinical decision making

Olchanski N, Hansen RN, Pope E, D'Cruz B, Fergie J, Goldstein M, Krilov LR, McLaurin KK, Nabrit-Stephens B, Oster G, Schaecher K, Shaya FT, Neumann PJ, Sullivan SD. Palivizumab Prophylaxis for Respiratory Syncytial Virus: Examining the Evidence Around Value. Open Forum Infect Dis. 2018 Feb 7;5(3):ofy031. doi: 10.1093/ofid/ofy031. eCollection 2018 Mar. Review.  PMID: 29516023    PMCID: PMC5833316
PubMed Central

Kuznik A, B├ęgo-Le-Bagousse G, Eckert L, Gadkari A, Simpson E, Graham CN, Miles L, Mastey V, Mahajan P, Sullivan SD. Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults. Dermatol Ther (Heidelb). 2017 Dec;7(4):493-505. doi: 10.1007/s13555-017-0201-6. Epub 2017 Sep 20.  PMID: 28933010    PMCID: PMC5698200
PubMed Central

Canestaro WJ, Hendrix N, Bansal A, Sullivan SD, Devine EB, Carlson JJ. Favorable and publicly funded studies are more likely to be published: a systematic review and meta-analysis. J Clin Epidemiol. 2017 Dec;92:58-68. doi: 10.1016/j.jclinepi.2017.08.004. Epub 2017 Aug 31. Review.  PMID: 28842289

Slejko JF, Basu A, Sullivan SD. Returns to scientific publications for pharmaceutical products in the United States. Health Econ. 2017 Jul 10. doi: 10.1002/hec.3546. [Epub ahead of print]  PMID: 28695605

Bansal A, Sullivan SD, Hershman DL, Lyman GH, Barlow WE, McCune JS, Ramsey SD. A stakeholder-informed randomized, controlled comparative effectiveness study of an order prescribing intervention to improve colony stimulating factor use for cancer patients receiving myelosuppressive chemotherapy: the TrACER study. J Comp Eff Res. 2017 Jul;6(5):461-470. doi: 10.2217/cer-2017-0005. Epub 2017 Jul 7.  PMID: 28686055

Member, dissertation committee for David Kim
Loss relative to Efficient Diffusion (LED) - A novel metric for economic evaluation of medical technology and its application to the evaluation of bariatric surgery